T. Rowe Price Associates’s NOV NOV Stock Holding History
Bought
Maintained
Sold
Other funds holding NOV
VPM
VCM
T. Rowe Price Associates's NOV Position: Q1 2026 in Review
T. Rowe Price Associates increased its NOV (NOV) stake by 37% in Q1 2026, buying an estimated $35M and bringing the position to 6,921,865 shares worth $130M. The position accounts for 0.02% of the portfolio, ranked #557.
T. Rowe Price Associates first reported a position in NOV in Q2 2013 and has held it in 52 quarters since. The position peaked at $290M in Q2 2014. 465 funds tracked by Wall St. Rank hold NOV as of Q1 2026.
- T. Rowe Price Associates held 6,921,865 shares of NOV worth $130M as of Q1 2026.
- T. Rowe Price Associates bought 1,862,465 NOV shares in Q1 2026, an estimated $35M.
- NOV made up 0.02% of T. Rowe Price Associates's portfolio in Q1 2026, its #557 holding.
- T. Rowe Price Associates first reported a position in NOV in Q2 2013 and has held it in 52 quarters since.
- T. Rowe Price Associates's NOV position peaked at $290M in Q2 2014.
- 465 funds tracked by Wall St. Rank held NOV as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.